Bioequivalence Study to Compare Selexipag 400mcg Film Coated Tablets (400 mcg Selexipag) Versus Uptravi® 400mcg Film Coated Tablets (400 mcg Selexipag)

Clinical trial NCT06932198 · COMPLETED

Trial details

NCT number: NCT06932198
Sponsor: Humanis Saglık Anonim Sirketi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension (PAH)

Start date: 2025-01-09
Primary completion: 2025-03-03
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.